Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: The two therapeutic strategies of surgical intervention and medical management in a patient with enhanced-fibrinolytic type of disseminated intravascular coagulation after aortic replacement for Stanford type A aortic dissection with chronic heart and renal failure

Fig. 3

Clinical course of the first admission. The hematoma around the CRT-D was not controlled with invasive procedures and recombinant soluble thrombomodulin. After removal and hemostasis of the periprosthetic vascular graft hematoma, the hematoma around the CRT-D did not recur and the DIC improved. APTTP, activated partial thromboplastin time; AT3, antithrombin III; CRT-D, cardiac resynchronization therapy-defibrillator; DIC, disseminated intravascular coagulation; FDP, fibrinogen degradation products; FFP, fresh frozen plasma; PAI-1, plasminogen activator inhibitor-I; PC, platelet concentrate; PIC, plasmin-α2-plasimin inhibitor complex; PT, prothrombin time; RBC, red blood cell; SF, soluble fibrin; TAT, thrombin-antithrombin complex

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us